Viewing StudyNCT00050011



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00050011
Status: COMPLETED
Last Update Posted: 2014-03-21
First Post: 2002-11-18

Brief Title: Zoledronic Acid - Letrozole Adjuvant Synergy Trial ZFAST - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive andor Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Osteoporosis
Breast Neoplasms
Keywords:
Name View
US32 View
cancer-treatment related bone loss View
postmenopausal women View
breast cancer View
hormone receptor positive breast cancer View
adjuvant therapy View
hormonal therapy View
bone loss View
bisphosphonates View
ZFAST View
Letrozole View
Zoledronic Acid View